查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1918311

全球醫用氣體市場－2026-2031年預測

Global Medical Gas Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 143 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計醫用氣體市場將從 2025 年的 163.76 億美元成長到 2031 年的 226.3 億美元，複合年成長率為 5.54%。

醫用氣體市場是現代醫療保健基礎設施的關鍵組成部分，涵蓋高純度氣體和混合氣體的生產、儲存、分銷和應用，用於治療、診斷和維持生命。該市場包括醫用氧氣、氧化亞氮、醫用空氣、二氧化碳、氮氣、氦氣和各種麻醉劑重要氣體。這些氣體的可靠供應對於醫院、手術中心、急診服務和居家醫療的正常運作至關重要，因此該行業既充滿活力又不斷發展。

成長催化劑和市場促進因素

慢性病和老齡化相關疾病在全球範圍內的日益流行是推動長期氧氣療法（LTOT）和呼吸支持設備需求成長的主要且持續的因素。慢性阻塞性肺病（COPD）、心血管疾病、氣喘和睡眠呼吸中止症等疾病直接增加了對長期氧氣治療和呼吸支持設備的需求。此外，全球人口老化和外科技術的進步導致手術數量不斷增加，也推動了麻醉氣體以及腹腔鏡手術和冷凍手術用氣體需求的穩定成長。

同時，醫療設備和治療方法的顯著進步正在擴大醫用氣體的應用範圍和消耗量。體外膜氧合（ECMO）在心臟衰竭衰竭治療中的日益普及，標誌著氧氣和二氧化碳的高強度應用。同樣，高流量氧氣鼻管（HFNC）氧氣療法、非侵入性通氣和先進霧化系統的廣泛應用，在提高呼吸治療效果的同時，也增加了對氣體的精確度和用量要求。這些技術不僅推動了對氣體的需求，也催生了對能夠確保安全可控給藥的整合輸送系統的需求。

市場區隔與應用重點

根據應用領域，市場可大致分為治療應用與診斷應用兩大類。治療應用領域佔據主導地位，涵蓋呼吸治療、麻醉、創傷治療（高壓氧氣療法）、疼痛管理等。診斷應用領域雖然規模較小，但對於肺部彌散測試（使用氦氣或一氧化碳）和診斷成像等應用至關重要。慢性病管理和重症監護等治療領域的成長尤為強勁。

供應鏈趨勢與關鍵問題

醫用氣體供應鏈監管嚴格且資本密集，從生產到使用環節都需要嚴格的品管。主要挑戰在於關鍵原料（尤其是氦氣）的價格和供應波動。氦氣是核磁共振成像儀和某些呼吸系統應用所必需的，但其供應地域集中，且易受地緣政治因素和產量波動的影響。這種波動會影響營運成本，因此氣體生產商和大型醫療網路必須進行策略採購和庫存管理。

確保供應鏈韌性和不間斷供應是重中之重，近期國際事件導致氧氣供應緊張，凸顯了這一點。為此，各國加大了對現場制氧設施（例如，變壓式吸附制氧裝置）的投資，提升了散裝儲存能力，並加強了物流合作，以緩解局部短缺和運輸夥伴關係。

區域展望：亞太地區將引領快速成長

亞太地區預計將成為醫用氣體市場成長最快的地區。這一成長主要得益於醫療基礎設施的大規模投資，包括在中國、印度和東南亞地區新建醫院和專科醫療中心。醫療成本上升、先進醫療服務的普及、慢性病患病率的增加以及政府為改善急診和重症監護服務而採取的舉措，共同促成了前所未有的市場需求。儘管北美和歐洲仍然是大規模、市場成熟且監管嚴格的地區，但亞太地區的成長軌跡正在改變全球需求格局，並吸引跨國燃氣公司的巨額投資。

競爭格局與策略挑戰

市場由大規模全球工業燃氣公司主導，這些公司在工業氣體和醫用氣體領域擁有廣泛的生產、物流和技術訣竅。競爭主要集中在以下幾個方面：

  • 可靠性和純度：透過強大的生產和分銷網路，確保 USP/醫用級品質和 24/7 全天候供應可靠性。
  • 綜合服務模式：不僅提供燃氣供應，還為醫療機構提供設備（歧管、流量計、警報器）、管道安裝、維護和合規管理服務。
  • 技術合作：與醫療設備製造商合作，開發用於 ECMO（體外膜氧合）和家庭氧氣療法等先進療法的整合解決方案。
  • 地理擴張：透過合資、收購或新投資，在快速成長的亞太市場建立生產和分銷基地。

醫用氣體市場正從通用型公用事業到一個高度複雜、技術驅動的產業轉型，成為先進醫療保健服務不可或缺的一部分。人口結構和流行病學趨勢為市場成長提供了結構性支撐，而醫療程序的創新不斷開拓新的應用領域。產業領導者的成功取決於能否應對原物料價格波動、建立具有韌性和靈活性的供應鏈，以及向高成長的亞太地區進行策略轉型。在此過程中，保持作為此關鍵醫療保健行業基石的卓越安全和品質標準至關重要。

本報告的主要優勢：

  • 深入分析：提供對主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
  • 競爭格局：了解全球主要企業的策略舉措，並了解透過正確的策略進入市場的可能性。
  • 市場促進因素與未來趨勢：探索推動市場的動態因素和關鍵趨勢，以及它們將如何塑造未來的市場發展。
  • 可操作的建議：利用這些見解，在快速變化的環境中製定策略決策，發展新的商業機會和收入來源。
  • 受眾廣泛：適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業，且經濟實惠。

企業使用我們的報告的目的是什麼？

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

  • 2021年至2025年的歷史數據和2026年至2031年的預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區（包括國家）分類的收入和預測評估
  • 公司概況（策略、產品、財務資訊）及主要發展動態。

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

5. 全球醫用氣體市場（依氣體類型分類）

  • 介紹
  • 氧
  • 氮
  • 二氧化碳
  • 其他

6. 全球醫用氣體市場依應用領域分類

  • 介紹
  • 治療
  • 診斷
  • 外科手術
  • 其他

7. 全球醫用氣體市場（以最終用戶分類）

  • 介紹
  • 醫院和診所
  • 手術中心
  • 其他

8. 全球醫用氣體市場（依地區分類）

  • 介紹
  • 北美洲
    • 依氣體類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依氣體類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 依氣體類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 德國
      • 法國
      • 英國
      • 西班牙
      • 義大利
      • 其他
  • 中東和非洲
    • 依氣體類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 依氣體類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 印尼
      • 泰國
      • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第10章：公司簡介

  • Matheson Tri-Gas, Inc.
  • Linde plc.
  • Air Liquide
  • Atlas Copco
  • Messer
  • Air Products and Chemicals Inc.
  • Taiyo Nippon Sanso Corporation（Mitsubishi Chemical Group）
  • INOX-Air Products Inc.
  • SOL Spa
  • NOVAIR SAS

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061616314

Medical Gas Market is projected to grow at a 5.54% CAGR, increasing from USD 16.376 billion in 2025 to USD 22.63 billion in 2031.

The medical gas market is a critical and foundational component of modern healthcare infrastructure, encompassing the production, storage, distribution, and application of high-purity gases and gas mixtures for therapeutic, diagnostic, and life-support purposes. This market includes essential gases such as medical oxygen, nitrous oxide, medical air, carbon dioxide, nitrogen, helium, and various anesthetic agents. The reliable supply of these gases is non-negotiable for the functioning of hospitals, surgical centers, emergency services, and home healthcare, making it a resilient yet technologically evolving sector.

Growth Catalysts and Market Drivers

A primary and sustained driver is the rising global prevalence of chronic and age-related diseases. Conditions such as chronic obstructive pulmonary disease (COPD), cardiovascular diseases, asthma, and sleep apnea directly increase the demand for long-term oxygen therapy (LTOT) and respiratory support. Furthermore, the growing volume of surgical procedures, driven by an aging global population and advancements in surgical techniques, fuels consistent demand for anesthetic gases and gases used in laparoscopic and cryosurgical applications.

Concurrently, significant technological advancements in medical devices and treatment modalities are expanding the applications and consumption of medical gases. The increased adoption of Extracorporeal Membrane Oxygenation (ECMO) for cardiac and respiratory failure represents a high-intensity use case for oxygen and carbon dioxide. Similarly, the proliferation of high-flow nasal cannula (HFNC) oxygen therapy, non-invasive ventilation, and advanced nebulizer systems enhances the efficacy of respiratory treatments but also increases the precision and volume of gas required. These technologies drive demand for both the gases and the integrated delivery systems that ensure their safe and controlled administration.

Market Segmentation and Application Focus

The market is broadly segmented by application into therapeutic and diagnostic uses. The therapeutic segment dominates, covering respiratory therapy, anesthesia, wound healing (using hyperbaric oxygen), and pain management. The diagnostic segment, though smaller, is vital for applications such as lung diffusion tests (using helium or carbon monoxide) and imaging. Growth is particularly robust in therapeutic areas linked to chronic disease management and critical care.

Supply Chain Dynamics and Critical Challenges

The medical gas supply chain is highly regulated, capital-intensive, and requires stringent quality control from production to point-of-use. A central challenge is price and supply volatility for key raw materials, most notably helium. Helium is critical for MRI scanners and certain respiratory applications, but its supply is geographically concentrated and subject to geopolitical and production fluctuations. This volatility can impact operational costs and necessitate strategic sourcing and inventory management for gas producers and large healthcare networks.

Ensuring supply chain resilience and uninterrupted delivery is paramount, as underscored by recent global events that strained oxygen supply. This has led to increased investment in on-site generation (e.g., pressure swing adsorption plants for oxygen), enhanced bulk storage capabilities, and stronger logistics partnerships to mitigate regional shortages and transportation bottlenecks.

Geographical Outlook: Asia-Pacific as the High-Growth Engine

The Asia-Pacific region is anticipated to be the fastest-growing market for medical gases. This growth is propelled by massive investments in healthcare infrastructure, including the construction of new hospitals and specialty care centers across China, India, and Southeast Asia. Rising healthcare expenditures, increasing accessibility to advanced medical treatments, a growing burden of chronic diseases, and government initiatives to improve emergency and critical care services are all converging to create unprecedented demand. While North America and Europe remain large, mature markets with stringent regulatory frameworks, APAC's growth trajectory is reshaping global demand patterns and attracting significant investment from multinational gas companies.

Competitive Landscape and Strategic Imperatives

The market is dominated by large, global industrial gas corporations that leverage their extensive production, logistics, and technology expertise across both industrial and medical segments. Competition centers on:

  • Reliability and Purity: Guaranteeing USP/medical-grade quality and 24/7 supply reliability through robust production and distribution networks.
  • Integrated Service Models: Offering not just gas, but also equipment (manifolds, flowmeters, alarms), pipeline installation, maintenance, and compliance management services for healthcare facilities.
  • Technology Partnerships: Collaborating with medical device manufacturers to develop integrated solutions for advanced therapies like ECMO and home oxygen therapy.
  • Geographic Expansion: Establishing production and distribution footprints in high-growth APAC markets through joint ventures, acquisitions, or greenfield investments.

The medical gas market is evolving beyond a commoditized utility into a sophisticated, technology-enabled segment vital for advanced healthcare delivery. Growth is structurally supported by demographic and epidemiological trends, while innovation in medical procedures continues to open new application avenues. Success for industry leaders depends on navigating raw material volatility, building resilient and flexible supply chains, and executing a strategic pivot toward the high-growth Asia-Pacific region, all while maintaining the impeccable safety and quality standards that are the bedrock of this essential healthcare sector.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Medical Gas Market Segmentation

  • By Gas Type
  • Oxygen
  • Nitrogen
  • Carbon Dioxide
  • Others
  • By Application
  • Therapeutic
  • Diagnostic
  • Surgery
  • Others
  • By End-User
  • Hospitals & Clinics
  • Surgical Centers
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. MEDICAL GAS MARKET BY GAS TYPE

  • 5.1. Introduction
  • 5.2. Oxygen
  • 5.3. Nitrogen
  • 5.4. Carbon Dioxide
  • 5.5. Others

6. MEDICAL GAS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Therapeutic
  • 6.3. Diagnostic
  • 6.4. Surgery
  • 6.5. Others

7. MEDICAL GAS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals & Clinics
  • 7.3. Surgical Centers
  • 7.4. Others

8. MEDICAL GAS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Gas Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Gas Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Gas Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Spain
      • 8.4.4.5. Italy
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Gas Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Gas Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. India
      • 8.6.4.3. Japan
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Matheson Tri-Gas, Inc.
  • 10.2. Linde plc.
  • 10.3. Air Liquide
  • 10.4. Atlas Copco
  • 10.5. Messer
  • 10.6. Air Products and Chemicals Inc.
  • 10.7. Taiyo Nippon Sanso Corporation (Mitsubishi Chemical Group)
  • 10.8. INOX-Air Products Inc.
  • 10.9. SOL Spa
  • 10.10. NOVAIR SAS

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations